WALTHAM, Mass., Sept. 21 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. , a leading manufacturer and marketer of rapid diagnostic products for the consumer and professional markets, announced today that it will attend the upcoming UBS Global Life Sciences Conference being held September 24-27, 2007 at the Grand Hyatt in New York, New York. Ron Zwanziger, Chairman, President, and Chief Executive Officer, and Jon Russell, Vice President, Finance, will attend. Their presentation is scheduled for Wednesday, September 26, 2007 at 12:00 p.m. and will be made available to the public through a webcast accessible through the company’s website at http://www.invmed.com/investors.cfm. A replay of the webcast will be available via the link above starting three hours after the actual presentation and will remain available until October 27, 2007. During their presentation Mr. Zwanziger or Mr. Russell may discuss and answer questions concerning business and financial developments and trends. Their responses to questions, as well as other matters discussed during the webcast, may contain or constitute information that has not been disclosed previously.
An investor presentation to be provided at the conference will be made available to the public on the company’s website via the link provided above.
By developing new capabilities in near-patient diagnosis, monitoring and health management, Inverness Medical Innovations enables individuals to take charge of improving their health and quality of life. A global leader in rapid point-of-care diagnostics, Inverness’ products, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women’s health. Inverness is headquartered in Waltham, Massachusetts.
Inverness Medical Innovations, Inc.
CONTACT: Doug Guarino, Director of Corporate Relations of InvernessMedical Innovations, Inc., +1-781-647-3900
